Opened to the public in July 2023, Beijing GoBroad Hospital is more than just a medical facility; it’s a dynamic ecosystem of clinical research, advanced patient care, and pioneering medical technology.

The hospital sprawls across a vast 100,000 square meters in the strategic locale of Zhongguancun Life Science Park, surrounded by Medical Road to the east, Science Park Road to the south, the Sixth Hospital of Beijing Medical Science to the west, and Yuhengnan Road to the north.

This prime positioning is not only crucial for accessibility but also places the hospital at the crossroads of collaboration among top-tier medical and research institutions.

Designed to accommodate 500 beds with specialized provisions like 75 beds for phase I clinical trials and an additional 24 for quantitative pharmacology, the hospital is tailored to handle a spectrum of medical scenarios, from routine procedures to the most challenging clinical cases.

Wealth of expertise

As a member of the GoBroad Healthcare Group established in 2017, Beijing GoBroad Hospital draws on a robust network of expertise and resources.

The hospital operates under a well-orchestrated infrastructure comprising four major centers: the Center for Challenging and Critical Care Medicine, the Clinical Research Center, the Precision Diagnosis Center, and the Data Intelligence Center.

These specialized hubs not only streamline patient care but also facilitate a seamless flow of information and innovation across various disciplines.

The hospital has rapidly become a magnet for leading clinical experts from around the globe. This diverse pool of talent fuels its mission to drive medical innovation and enhance patient outcomes.

With more than half of its team dedicated to transforming clinical innovations into practical solutions, Beijing GoBroad Hospital stands at the forefront of medical advancements.

An ecosystem of medical innovation

At Beijing GoBroad Hospital, innovation is not confined to the laboratories; it permeates every aspect of patient care. The facility boasts a comprehensive suite of specialized service teams, including the Early Clinical Research Center, Central Laboratory, Imaging Center, Pathology Center, and Clinical Evaluation Center for Cardiac Safety, among others.

These teams are critical in propelling the hospital’s research initiatives from theory to therapy, ensuring that new treatments are not only imagined but also implemented with precision and care.

The focus areas of the hospital—solid tumors, hematologic tumors, and brain science—are among the most complex fields in medicine today.

By specializing in these areas, Beijing GoBroad Hospital not only tackles some of the most critical challenges in healthcare but also offers new hope to patients who previously had limited options.

A legacy of innovation and compassion

Since its inception, Beijing GoBroad Hospital has experienced exponential growth and development.

The hospital has become a pivotal force in the medical community, facilitating hundreds of innovative pharmaceutical trials and serving tens of thousands of patients with challenging and critical conditions.

Each success story adds to the hospital’s legacy of excellence and innovation in healthcare.

Looking to the future

The vision of Beijing GoBroad Hospital extends beyond the immediate horizon. It is an integral part of the GoBroad Healthcare Group’s broader strategy to create a unique Academic-Led Clinical Research Organization (ARO).

This innovative model bridges clinical discovery with basic research, industry translation, and clinical application, thereby enhancing the development efficiency and quality within the biopharmaceutical industry.

As Beijing GoBroad Hospital continues to grow and evolve, it remains steadfast in its commitment to its foundational philosophy—putting patients’ needs first.

Through breakthrough technologies and a relentless pursuit of excellence, Beijing GoBroad Hospital is not just shaping the future of medical care; it is redefining it.

Beijing GoBroad Hospital is located in Changping District.

The hospital is designed to accommodate 500 beds with specialized provisions like 75 beds for phase I clinical trials and an additional 24 for quantitative pharmacology.

Since its inception, Beijing GoBroad Hospital has experienced exponential growth and development.